Quantum Computing, Inc. (QUBT) is preparing to disclose its Q4 FY25 earnings on March 2, 2026. Analysts predict that the company will report a loss of $0.02 per share, marking a notable improvement from the $0.47 loss recorded in the same quarter last year. Revenue forecasts stand at $390,000, a significant increase from the $62,000 reported in Q4 2024.
Leading up to the earnings release, QUBT”s stock has experienced a downturn, falling by 8.4% on February 27 to close at $8.278. The trading volume on that day was approximately 3.37 million shares, which is about 78% lower than its average volume of 15 million. Such a low-volume decline may indicate a lack of strong conviction among investors, but it does not fully capture the underlying dynamics at play.
The stock is currently trading below its 50-day moving average of $10.35 and its 200-day moving average of $13.70. Despite this recent dip, QUBT has gained over 39% in value over the past year, largely attributed to growing investor interest in its innovative photonic technology.
Acquisition of Luminar Semiconductor
A key focus for investors will be the implications of QUBT”s recent $110 million all-cash acquisition of Luminar Semiconductor Inc., previously part of Luminar Technologies. This strategic acquisition is aimed at enhancing QUBT”s control over its technology stack and facilitating a pathway toward consistent revenue generation. During the earnings call, stakeholders will be keen to hear updates regarding chip production timelines, order deliveries, and any early indicators of revenue progress stemming from this deal.
Analyst Sentiment and Market Position
Analyst opinions on QUBT exhibit a mixed outlook. Lake Street”s Max Michaelis has retained a “Buy” rating but has lowered his price target from $24 to $16, suggesting a potential upside of around 77% from the current trading levels. Similarly, Ascendiant Capital Markets has revised its target from $40 to $25 while maintaining a “Buy” recommendation. In contrast, Wedbush has initiated coverage with a “Neutral” rating and a price target of $12, while Cantor Fitzgerald echoes this sentiment with a neutral stance and a $15 target.
Meanwhile, Rosenblatt Securities recently began coverage with a “Buy” rating, setting a target of $22. Overall, the consensus among analysts is categorized as a Moderate Buy, comprising one Strong Buy, two Buys, two Holds, and one Sell. The average price target across these analysts is $18.00, indicating a potential increase of approximately 99% from the stock”s trading position on February 27.
QUBT is characterized by a high beta of 3.44, signifying substantial volatility relative to the broader market. The company”s market capitalization is estimated at $1.83 billion, while its price-to-earnings (P/E) ratio stands at a negative -13.40, indicating its pre-profitability status. Additionally, insider ownership is reported at 19.3%, with COO Milan Begliarbekov having sold 2,860 shares on January 7 at $11.85 each, which reduced his stake by approximately 10.55%. Institutional ownership remains relatively low at 4.26%.
As QUBT prepares to release its Q4 FY25 results before the market opens on March 2, 2026, options traders are anticipating a significant price movement, with expectations of a potential 14.05% shift in either direction following the earnings announcement.
